An Institute for Health Metrics and Evaluation report published in The Lancet alleges that only 7.4 million children, out of almost 14 million claimed by the GAVI Alliance, had been immunized against diphteria, pertussis (whooping cough) and tetanus (DPT3 vaccine) under a program operated by the aid group.
Philip Stevens, the health program director of the International Policy Network, a London-based think-tank specializing in development issues, told the Associated Press: "with the unprecedented billions given by the international community, there is no excuse for these poor coverage rates." He added: "one has to wonder where the money has gone, hopefully not into Swiss bank accounts."
In a statement, the Geneva, Switzerland-based group, has responded to claims made by the IHME, by inviting its head, Chris Murray, to join a task force to evaluate the quality of GAVI's own figures, which are based on World Health Organization- and UNICEF-validated data. A spokesman for the GAVI Alliance told the Marketletter that the team was formed in early 2008.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze